Answers are grounded in this paper and cite their sources.
In rectal cancer patients with a cCR following neoadjuvant chemoradiotherapy, a Watch and Wait policy appears feasible and safe. Robust surveillance with early detection of regrowths allows a high rate of successful salvage surgery, without an increase in the risk of systemic disease, or adverse survival outcomes.
No takes yet. Share an insight, caveat, or question.
Dattani et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: